Anne Bergeron
Bergeron-Lafaurie, Anne, 19..-....
Bergeron-Lafaurie, Anne
VIAF ID: 210106118 (Personal)
Permalink: http://viaf.org/viaf/210106118
Preferred Forms
- 100 0 _ ‡a Anne Bergeron
- 100 1 _ ‡a Bergeron-Lafaurie, Anne
- 100 1 _ ‡a Bergeron-Lafaurie, Anne, ‡d 19..-....
4xx's: Alternate Name Forms (7)
Works
Title | Sources |
---|---|
Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels | |
[Allergic bronchopulmonary aspergillosis: Evaluation of a maintenance therapy with nebulized Ambisome®]. | |
Aspergillose pulmonaire invasive chez les patients ayant une hémopathie lymphoïde | |
[BCG infection following intravesicular immunotherapy for bladder cancer] | |
Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study | |
Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis. | |
Circulating Aspergillus fumigatus DNA Is Quantitatively Correlated to Galactomannan in Serum | |
Clinical characteristics and prognostic factors of pulmonary MALT lymphoma. | |
Contribution of 2-photon microscopy for exploration of lung involvement after murine model infection with Influenzavirus. | |
Cystic Pulmonary Myxoid Liposarcoma Mimicking Endobronchial Blood Clot. | |
Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10 | |
Cytokines and pulmonary granulomatous diseases and fibrotic disorders. | |
Cytokines et maladies pulmonaires granulomateuses et fibrosantes | |
Dasatinib-induced lupus | |
[Diagnostic approach to infectious lung diseases in patients immunocompromised by HIV] | |
Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial | |
Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease. | |
ETUDE COMPARATIVE DES PROFILS DE CYTOKINES DANS LES GANGLIONS TUBERCULEUX ET SARCOIDIENS | |
[Evidence based pneumology: 3rd update workshop to the SPLF. Idiopathic diffuse interstitial pneumopathies] | |
[Groupe pour la recherche et l'enseignement en pneumo-infectiologie (GREPI): The ball is rolling…] | |
[Guidelines for the management of dasatinib | |
[Haematological pulmonary disease, an avenue to explore] | |
Human metapneumovirus pneumonia in patients with hematological malignancies. | |
Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature. | |
IFNγ and antibody responses among French nurses during a tuberculosis contact tracing investigation | |
In situ expression of B7 and CD40 costimulatory molecules by normal human lung macrophages and epithelioid cells in tuberculoid granulomas | |
Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. | |
Koebner Phenomenon in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) | |
Lazarus Syndrome With Crizotinib in a Non-Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation | |
Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation | |
Lung Abnormalities after Dasatinib Treatment for Chronic Myeloid Leukemia | |
Lung disease in adult common variable immunodeficiency | |
[The lung in haematology diseases: end of a series, the adventure continues] | |
[Lung involvement in lymphoid and lympho-plasmocytic proliferations (except lymphomas)] | |
Myocardial ischemia and infarction associated with vinorelbine. | |
New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards | |
New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined? | |
Non-infectious pulmonary complications of myelodysplastic syndromes and chronic myeloproliferative disorders | |
[Orphan diseases: what's new since 2005?] | |
Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis | |
Phenomenological, experiential and experimental approach to dyspnea invisibility. | |
Polyomaviruses KI and WU in immunocompromised patients with respiratory disease | |
Primary Epstein-Barr virus infection with pneumonia transmitted by allogeneic bone marrow after transplantation | |
The prognosis of acute respiratory failure in critically ill cancer patients | |
Prognostic biomarkers and risk stratification in PAH. | |
Prospective evaluation of the efficacy of the combination of budesonide/formoterol in obstructive airway disease after allogeneic hematopoietic stem cell transplantation | |
Pulmonary arterial hypertension in patients treated by dasatinib | |
Pulmonary Complications of Bcr-Abl Tyrosine Kinase Inhibitors | |
The pulmonologist's point of view on lung infiltrates in haematological malignancies. | |
[Rare and orphan diseases--a national priority] | |
Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. | |
Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis | |
Respiratory infections caused by slow-growing bacteria: Nocardia, Actinomyces, Rhodococcus | |
Response assessment in invasive aspergillosis. | |
Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation | |
Scanner thoracique précoce après allogreffe de cellules souches hématopoïétiques : description de la population concernée et impact sur la prise en charge | |
Screening for tuberculosis before TNFα antagonist initiation: Are current methods good enough? | |
Small airway diseases and immune deficiency | |
[The specific pulmonary manifestations of acute myeloid leukaemia] | |
The spectrum of lung involvement in collagen vascular-like diseases following allogeneic hematopoietic stem cell transplantation: report of 6 cases and review of the literature | |
The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. | |
Study of the pulmonary side effects associated with the price of dasatinib : Role of the perturbation of the pulmonary endothelium functions. | |
Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis. | |
Validation de deux scores pronostiques d'infection à VRS dans une cohorte multicentrique de patients allogreffés de cellules souches hématopoïétiques | |
Viral respiratory infections diagnosed by multiplex PCR after allogeneic hematopoietic stem cell transplantation: long-term incidence and outcome | |
Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial |